nb-002
Small moleculeexperimental
Clinical trial activity
2 trials · 21 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2007 (NCT00453271)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nb-002
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05924906 | Phase 1 | Oct 31, 2023 | Suzhou Neologics Bioscience Co., Ltd. |
| NCT00453271 | Phase 2 | Jan 1, 2007 | BlueWillow Biologics, Centre de Recherche Dermatologique du Quebec Metropolitaine, Dermatology Research Center, Inc, Derm Research Incorporated, Eastern Canada Cutaneous Research Associates Ltd., Endeavor Clinical Trials, EntraLogix Clinical Group Inc., Innovaderm, International Dermatology Research Inc., J&S Studies Inc., K. Papp Clinical Research, Lynderm Research Inc, Minnesota Clinical Study Center, NewLab Clinical Research, Northwest Clinical Trials, Oregon Dermatology and Research Center, Oregon Medical Research Center, The Guenther Dermatology Research Centre, UltraNova Skincare, Virginia Clinical Research, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (21)
21 organizations
Page 1 / 2